Worms for immune regulation of multiple sclerosis
Worms for immune regulation of multiple sclerosis
What it found
No results found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Necator americanus
What it measured
Main measures
The primary endpoint is the cumulative number of new or enlarging Gd+ lesions at month 9
MRI lesions
Who could take part
Relapsing MS
Show the full criteria
Inclusion criteria
Inclusion: Inclusion criteria Exclusion: Exclusion criteria
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Whether controlled parasitic infection with N. americanus (25 larvae per patient) reduces the cumulative number of gadolinium enhancing (Gd+) lesions in MS at month 9 in comparison to baseline and placebo.
Loading reviews and guidelines…
History
Started
May 2011
Assembled by software from public sources.